CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Enzyme
Enzyme

Enzyme

Enzyme: Cloud-based QMS for life sciences' FDA approval & compliance.

Operating headquarters
San Francisco, CA, US🇺🇸
Founded
2017
Accelerator
Y Combinator logoY CombinatorS17
Overview
M & A
Analysis
Compare
Fundraising
Employees
News
Library

Enzyme Corporation, based in South San Francisco, offers Enzyme eQMS, a cloud-based quality management system for medical device, digital health, and biopharma teams. The platform spans core, premarket, and postmarket modules including document control, change control, training, design control, risk management, suppliers, audits, complaints, nonconformance, and CAPA, and is 21 CFR Part 11 compliant and validated out of the box with integrations to common engineering tools.

Alongside software, Enzyme provides quality, regulatory, and engineering consulting, supporting submissions, audits, and quality-system implementation for startup and enterprise teams. The company participated in the Y Combinator summer batch and was acquired by Greenlight Guru in July 2025, with its site noting a continued transition for Enzyme customers.

Enzyme - M & A Snapshot

Open M & A

  • Greenlight Guru

    Acquired Enzyme • Undisclosed • Jul 24, 2025

  • Roivant Sciences

    Acquired Enzyme • Undisclosed • Jan 1, 2022

Enzyme - Products & Services

  • Enzyme Consulting logo

    Enzyme Consulting

    Quality, regulatory, and engineering consulting for life sciences product teams from product inception through regulatory approval.

    Competing Products

    Emergo by UL logo
    NAMSA logo
    The FDA Group logo
    Veranex logo
  • Enzyme eQMS logo

    Enzyme eQMS

    Cloud-based electronic quality management system covering document, change, training, design, risk, supplier, audit, complaint, nonconformance, and CAPA workflows.

    Competing Products

    ComplianceQuest logo
    Greenlight Guru logo
    MasterControl logo

Enzyme - Similar Companies

The FDA Group logo

The FDA Group

thefdagroup.com

Veranex logo

Veranex

veranex.com

Emergo by UL logo

Emergo by UL

emergobyul.com

NAMSA logo

NAMSA

namsa.com

ComplianceQuest logo

ComplianceQuest

MasterControl logo

MasterControl

mastercontrol.com

Greenlight Guru logo

Greenlight Guru

greenlight.guru

Factored Quality logo

Factored Quality

Enablon logo

Enablon

enablon.com

Menlo Park Software logo

Menlo Park Software

InfinityQS logo

InfinityQS

infinityqs.com

Cority logo

Cority

cority.com

Leucine logo

Leucine

leucinetech.com

Bluenote logo

Bluenote

bluenote.ai

FastQS logo

FastQS

fastqs.com

Enzyme - Quick Facts

Who are Enzyme's competitors?

Companies similar to Enzyme include The FDA Group, Veranex, Emergo by UL and NAMSA.

When was Enzyme founded?

Enzyme was founded in 2017.

Where is Enzyme's headquarters located?

Enzyme's headquarters is located in San Francisco, CA, US.

How much disclosed funding has Enzyme raised?

As of Jul 23, 2025, Enzyme has disclosed funding of $2M (USD). Undisclosed round amounts are excluded.

Enzyme - Classification

Ownership
  • Venture Capital
Technology
  • Cloud
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software